Tanabe M, Sekimata M, Ferrone S, Takiguchi M
Department of Tumor Biology, University of Tokyo, Japan.
J Immunol. 1992 May 15;148(10):3202-9.
To identify mAb reacting with the HLA class I alpha 3 domain, 14 mAb recognizing monomorphic determinants expressed on HLA-A, B, and C Ag or restricted to HLA-B Ag were screened in indirect immunofluorescence with mouse L cells expressing HLA-B7/H-2Kb chimeric Ag. mAb CR1S63, CR10-215, CR11-115, and W6/32 were found to react with the HLA class I alpha 3 domain in addition to the alpha 2 domain. mAb Q1/28 and TP25.99 were found to react only with the HLA class I alpha 3 domain. The determinants recognized by the six mAb were mapped on the HLA class I alpha 3 domain by indirect immunofluorescence staining of L cells expressing H-2Kb Ag containing different segments of the HLA-B7 alpha 3 domain chimerized with the H-2Kb alpha 3 domain. mAb TP25.99 reacts with chimeric Ag containing the HLA-B7 184 to 199 stretch, mAb CR10-215 and CR11-115 react with chimeric Ag containing the HLA-B7 184 to 246 stretch, mAb CR1S63 and Q1/28 react with chimeric Ag containing the HLA-B7 184 to 256 stretch, and mAb W6/32 reacts with chimeric Ag containing the whole HLA-B7 alpha 3 domain. Functional analysis using human CD8 alpha-bearing mouse H-2Kb-specific T cell hybridoma cells (HTB-Leu2) showed that only mAb TP25.99 inhibited IL-2 production by HTB-Leu2 cells stimulated with L cells expressing KbKbB7 Ag. This inhibition may occur because of the spatial proximity of the determinant defined by mAb TP25.99 to the CD8 alpha binding loop and/or because of change(s) in the conformation of the CD8 alpha binding loop induced by the binding of mAb TP25.99 to the HLA class I molecule. Furthermore, mAb TP25.99 inhibited the cytotoxicity of CD8-dependent and CD8-independent CTL clones. These results indicate that mAb TP25.99 has unique specificity and functional characteristics. Therefore it represents a valuable probe to characterize the role of the HLA class I alpha 3 domain in immunologic phenomena.
为鉴定与HLA I类α3结构域反应的单克隆抗体(mAb),我们用表达HLA - B7/H - 2Kb嵌合抗原的小鼠L细胞进行间接免疫荧光检测,筛选了14种识别在HLA - A、B和C抗原上表达的单态决定簇或局限于HLA - B抗原的单克隆抗体。发现单克隆抗体CR1S63、CR10 - 215、CR11 - 115和W6/32除了与α2结构域反应外,还与HLA I类α3结构域反应。发现单克隆抗体Q1/28和TP25.99仅与HLA I类α3结构域反应。通过对表达含有与H - 2Kbα3结构域嵌合的HLA - B7α3结构域不同片段的H - 2Kb抗原的L细胞进行间接免疫荧光染色,将这6种单克隆抗体识别的决定簇定位在HLA I类α3结构域上。单克隆抗体TP25.99与含有HLA - B7 184至199片段的嵌合抗原反应,单克隆抗体CR10 - 215和CR11 - 115与含有HLA - B7 184至246片段的嵌合抗原反应,单克隆抗体CR1S63和Q1/28与含有HLA - B7 184至256片段的嵌合抗原反应,单克隆抗体W6/32与含有整个HLA - B7α3结构域的嵌合抗原反应。使用携带人CD8α的小鼠H - 2Kb特异性T细胞杂交瘤细胞(HTB - Leu2)进行的功能分析表明,只有单克隆抗体TP25.99能抑制用表达KbKbB7抗原的L细胞刺激的HTB - Leu2细胞产生白细胞介素 - 2。这种抑制可能是由于单克隆抗体TP25.99定义的决定簇与CD8α结合环在空间上接近,和/或由于单克隆抗体TP25.99与HLA I类分子结合诱导的CD8α结合环构象变化。此外,单克隆抗体TP25.99抑制CD8依赖性和CD8非依赖性细胞毒性T淋巴细胞(CTL)克隆的细胞毒性。这些结果表明单克隆抗体TP25.99具有独特的特异性和功能特性。因此,它是表征HLA I类α3结构域在免疫现象中作用的有价值的探针。